Nina Oktafianti Marfu'ah

= http://dx.doi.org/10.20473/cimrj.v2i1.23972
Abstract views = 144 times | downloads = 65 times


Mixed connective tissue disease (MCTD) is an overlap disease, has been recognized as an entity disease with a mixture of clinical manifestations from systemic lupus erythematosus (SLE), systemic sclerosis (SSc), polymyositis/dermatomyositis, and rheumatoid arthritis, accompanied by the presence of high titers antibodies to U1 ribonucleoprotein (anti-U1RNP). We had reported case of a male patient who has chronic dysphagia, progressive dyspnea, and the presence of skin lesions. Based on the examination, it was found chronic dysphagia, progressive dyspnea caused by pneumonia and suspected interstitial lung disease, autoimmune hemolytic anemia, discoid lesions, and skin biopsy revealed scleroderma. This patient did not meet the diagnostic criteria of MCTD because anti-U1RNP examination had not been performed as one of the requirements in the diagnostic criteria. However, because he has strong signs and symptoms toward MCTD where there were overlapping symptoms of SLE as well as symptoms of SSc, so we diagnosed him as MCTD.

Full Text:



Bennett, R. M. (2017). “Overlap Syndromes,” in Kelley and Firestein’s Textbook of Rheumatology, eds. G. S. Firestein, R. C. Budd, S. E. Gabriel, I. B. McInnes, and Ja. R. O’Dell (Philadelphia: Elsevier), 1489–1509.

Ferucci, E., Johnston, J., Gordon, C., Helmick, C., and Lim, S. (2017). Prevalence of mixed connective tissue disease in a population-based registry of American Indian/Alaska Native people in 2007. Arthritis Care Res. 69(8), 68, 1271–1275. doi:10.1002/acr.

Hajas, A., Szodoray, P., Nakken, B., Gaal, J., Zold, E., Laczik, R., et al. (2013). Clinical course, prognosis, and causes of death in mixed connective tissue disease. J. Rheumatol. 40, 1134–1142. doi:10.3899/jrheum.121272.

Hoffman, R. W., and Greidinger, E. L. (2013). Mixed Connective Tissue Disease and Undifferentiated Connective Tissue Disease. 8th ed. , eds. D. J. Wallace and B. H. Hahn Philadelphia: Elsevier Available at: http://linkinghub.elsevier.com/retrieve/pii/B9781437718935000364.

Katewa, R., R.S., J., and G.L., B. (2014). Mixed connective tissue disorder: A case report. Int. J. Case Reports Images 5, 650. doi:10.5348/ijcri-2014116-cr-10427.

Mugunthan, M. (2005). Antinuclear antibodies-negative systemic lupus erythematosus – does it exist ? 2005.

Ortega-Hernandez, O. D., and Shoenfeld, Y. (2012). Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment. Best Pract. Res. Clin. Rheumatol. 26, 61–72. doi:10.1016/j.berh.2012.01.009.

Reiseter, S., Gunnarsson, R., Corander, J., Haydon, J., Lund, M. B., Aaløkken, T. M., et al. (2017). Disease evolution in mixed connective tissue disease: Results from a long-term nationwide prospective cohort study. Arthritis Res. Ther. 19, 1–9. doi:10.1186/s13075-017-1494-7.

Tendean, M., Nuriawan, S. A., and Nugroho, P. (2018). Interstitial lung disease in mixed connective tissue disease. Indones. J. Rheumatol. 9, 29–34. doi:10.37275/ijr.v9i1.68.


  • There are currently no refbacks.

Copyright (c) 2021 Nina Oktafianti Marfu'ah

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


View CIMRJ Stats

e-ISSN: 2721-544X

Lisensi Creative Commons
This Journal is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.